CL
Climb Bio, Inc. (CLYM)
NASDAQ·Healthcare·Biotechnology
$12.15
-1.22%
Mkt Cap $870.03M
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
Implied Upside
+64.7%
Consensus $20.00 vs current $12.15
NASDAQ·Healthcare·Biotechnology
$12.15
-1.22%
Mkt Cap $870.03M
Buy
12
Hold
0
Sell
0
Price Target (8 analysts)
$20.00
Range $17.00 – $25.00
+64.7%
Consensus $20.00 vs current $12.15